6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Regencell Bioscience Holdings Ltd
Filed: February 28, 2023
Period of Report: February 28, 2023
Accession Number: 0001213900-23-015052

View Document ↗ View on SEC.gov ↗